Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives Consensus Recommendation of “Hold” from Brokerages
Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) have been assigned an average rating of “Hold” from the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating […]
Shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) have been assigned an average rating of “Hold” from the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating […]
